Aloe barbadensis
Primary Active
Mechanism:Tyrosinase Inhibition
Key Compounds:Aloesin, Aloe-emodin
Azadirachta indica
Supportive
Mechanism:Anti-inflammatory
Key Compounds:Nimbolide, Azadirachtin
Ocimum sanctum
Supportive
Mechanism:Antioxidant
Key Compounds:Rosmarinic Acid, Eugenol
Mechanism of Action
UV Stress
Tyrosinase Enzyme
Melanin Production
*The formulation targets the rate-limiting enzyme (Tyrosinase) primarily via Aloe vera's aloesin content.
Scientific Confidence Matrix
In Vitro (Lab)
80/100
In Vivo (Animal)
60/100
Human Clinical
45/100
Safety Profile
90/100
Evidence Breakdown:
- Aloe Vera: Strongest support; clinical RCTs show improvement in MASI scores for melasma.
- Neem/Tulsi: Primarily antioxidant/soothing; lack of direct pigmentation trials in humans.
- Formulation: Rinse-off format limits systemic absorption risk but may reduce contact time.
Contraindications
- Known hypersensitivity to Aloe or Tulsi.
- Active eczema, broken skin, or infections.
- Children under 12 (lack of safety data).
Risk Mitigation
- Patch Test: Mandatory 24h behind ear.
- Sunscreen: Pair with SPF 30+ always.
- Rinse-Off: Ensure full removal from skin.
Escalation Protocol
Mild Stinging
Continue; Monitor
Persistent Redness
Stop; Use every other day
Blistering/Hives
Immediate Discontinuation
8-Week Monitoring Timeline
Baseline
MASI Score, Photos, Patch Test
Week 1-2
Check for Erythema & Stinging
Week 4
Subjective Brightness Check
Week 8
Final Efficacy Assessment
Selection Criteria
Ideal Candidate
Adults (18-65) with mild melasma seeking botanical alternatives.
Exclusion
Pregnancy, breastfeeding, or severe active inflammatory acne.